Combined Lactulose H2-breath Test With Abdominal Imaging | MicrobiomeTrials← Back to trialsNCT07145580
Combined Lactulose H2-breath Test With Abdominal Imaging
RecruitingOBSERVATIONAL
Trial Details
Start: 2025-08-01Est. Completion: 2025-12-31
Enrollment target: 500 participants Locations- Klinik Arlesheim, Arlesheim, Basel-Landschaft, Switzerland
Other microbiome trials you might be interested in
Cystic FibrosisCystic Fibrosis-related Diabetes
The goal of this study is to determine the extent to which excess dietary sugars serve as a precipitating factor in gluc…
Atlanta, United StatesEst. completion Jun 30, 2028
Obesity, Morbid
Currently, one anastomosis gastric bypass (OAGB) or mini-gastric bypass (MGB) is a common bariatric procedure for treati…
Astana, KazakhstanCompleted Apr 5, 2024
Celiac Disease in Children
Gluten Enteropathy
Diet; Deficiency
Adherence, Treatment
Celiac disease (CD) is an autoimmune gastrointestinal disease that is caused by intolerance to gluten in the diet. The m…
Edmonton, CanadaCompleted Jan 31, 2024